Lataa...
Adverse drug reactions in neonates and infants: a population-tailored approach is needed
Drug therapy is a powerful tool to improve outcome, but there is an urgent need to improve pharmacotherapy in neonates through tailored prevention and management of adverse drug reactions (ADRs). At present, infants commonly receive off-label drugs, at dosages extrapolated from those in children or...
Tallennettuna:
| Julkaisussa: | Br J Clin Pharmacol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley & Sons, Ltd
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4594721/ https://ncbi.nlm.nih.gov/pubmed/24862557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12430 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|